Pre-Operative Workup of Cochlear Implant

Hearing loss, an increasing problem across the globe, results in an important solution in the form of cochlear implants, highlighting the critical need for effective interventions. This review involves analyzing 46 relevant publications via databases such as PubMed and Google Scholar, providing current insights into pre-operative issues. Studies through databases such as PubMed and Google Scholar, ensuring contemporary insights into the pre-operative considerations. The pre-operative evaluation encompasses medical history, covering prenatal events and immediate post-natal health, along with physical examinations and complete audiometric assessments. High-Resolution Computed Tomography (HRCT) and Magnetic Resonance Imaging (MRI) emerge as crucial imaging techniques, guiding surgical planning and electrode placement. Brainstem Evoked Response Audiometry (BERA) supplements inconclusive MRI data, while vestibular screening aids in candidate selection. Cochlear duct length determination, often assessed through imaging techniques, contributes to optimal electrode array selection. Models in cochlear implant research, spanning computational, animal, tissue engineering, and physical models, further enhance our understanding and refinement of cochlear implant designs. In conclusion, this comprehensive pre-operative workup plays a significant role in assessing patient health, identifying causes of deafness, and contributing to the overall success of cochlear implantation, a transformative solution for profound hearing impairment

Effect of indoor environmental quality on visual comfort and productivity in office buildings

This is an accepted manuscript of an article published by Emerald in Journal of Engineering Design and Technology on 15/11/2021, available online: https://doi.org/10.1108/JEDT-09-2021-0474 The accepted version of the publication may differ from the final published version.Purpose: The Purpose of this paper is to identify statistical relationships between visual environment and occupant productivity. Visual environment is one of the most important indoor environmental quality (IEQ) parameters, and it directly impacts occupant productivity in offices. The literature outlines the significance of the impact. Still, there is a lack of investigation, statistical analysis and inter-relationships between the independent variables (IEQ factors), especially in the hot and arid climate. Design/methodology/approach: This study presents a research study investigating the effects and shows statistical relationships between IEQ on occupant comfort and productivity. The study was conducted in the Middle East, and data was collected for 12 months. It used the response surface analysis to perform analysis. Findings: This study outlined seven unique relationships highlighting the recommended range, inter-dependencies. Results include that illumination has maximum effect on visual comfort and temperature, daylight having direct influence and relative humidity, wall type next to the seat and kind of workspace also impact visual comfort and productivity. These findings would help to improve occupant comfort and productivity in office buildings. It is recommended to include results and recommendations on design guidelines for office buildings. Originality/value: This study presents the unique effects of non-visual IEQ parameters on visual comfort and productivity. This investigation also provides a unique method to develop the statistical relationship between various indoor environmental factors and productivity in different contexts and buildings.Published onlin

Assessment of perceptual distortion boundary through applying reversible watermarking to brain MR images

The digital medical workflow faces many circumstances in which the images can be manipulated during viewing, extracting and exchanging. Reversible and imperceptible watermarking approaches have the potential to enhance trust within the medical imaging pipeline through ensuring the authenticity and integrity of the images to confirm that the changes can be detected and tracked. This study concentrates on the imperceptibility issue. Unlike reversibility, for which an objective assessment can be easily made, imperceptibility is a factor of human cognition that needs to be evaluated within the human context. By defining a perceptual boundary of detecting the modification, this study enables the formation of objective guidelines for the method of data encoding and level of image/pixel modification that translates to a specific watermark magnitude. This study implements a relative Visual Grading Analysis (VGA) evaluation of 117 brain MR images (8 original and 109 watermarked), modified by varying techniques and magnitude of image/pixel modification to determine where this perceptual boundary exists and relate the point at which change becomes noticeable to the objective measures of the image fidelity evaluation. The outcomes of the visual assessment were linked to the images Peak Signal to Noise Ratio (PSNR) values, thereby identifying the visual degradation threshold. The results suggest that, for watermarking applications, if a watermark is applied to the 512x512 pixel (16 bpp grayscale) images used in the study, a subsequent assessment of PSNR=82dB or greater would mean that there would be no reason to suspect that the watermark would be visually detectable. Keywords: Medical imaging; DICOM; Reversible Watermarking; Imperceptibility; Image Quality; Visual Grading Analysis

Digital watermarking : applicability for developing trust in medical imaging workflows state of the art review

Medical images can be intentionally or unintentionally manipulated both within the secure medical system environment and outside, as images are viewed, extracted and transmitted. Many organisations have invested heavily in Picture Archiving and Communication Systems (PACS), which are intended to facilitate data security. However, it is common for images, and records, to be extracted from these for a wide range of accepted practices, such as external second opinion, transmission to another care provider, patient data request, etc. Therefore, confirming trust within medical imaging workflows has become essential. Digital watermarking has been recognised as a promising approach for ensuring the authenticity and integrity of medical images. Authenticity refers to the ability to identify the information origin and prove that the data relates to the right patient. Integrity means the capacity to ensure that the information has not been altered without authorisation. This paper presents a survey of medical images watermarking and offers an evident scene for concerned researchers by analysing the robustness and limitations of various existing approaches. This includes studying the security levels of medical images within PACS system, clarifying the requirements of medical images watermarking and defining the purposes of watermarking approaches when applied to medical images

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. METHODS: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. FINDINGS: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. INTERPRETATION: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic. FUNDING: Bill & Melinda Gates Foundation

A Novel Rotor Harmonic Winding Configuration for the Brushless Wound Rotor Synchronous Machine

In the last decade, permanent magnet (PM)-free or hybrid PM machines have been extensively researched to find an alternative for high cost rare-earth PM machines. Brushless wound rotor synchronous machines (BL-WRSMs) are one of the alternatives to these PM machines. BL-WRSMs have a lower torque density compared to PM machines. In this paper, a new topology is introduced to improve the torque producing capability of the existing BL-WRSM by utilizing the vacant spaces in the rotor slots. The new topology has two harmonic windings placed on the rotor which induce separate currents. A capacitor is used between the two harmonic windings to bring the currents in phase with each other. The harmonic winding currents are fed to the rectifier which is also placed on the rotor. Due to additional harmonic winding, the overall field current fed to the rotor field winding has been increased and hence the average torque has also increased. Finite element analysis (FEA)-based simulations are performed using ANSYS Maxwell to validate the proposed topology. The results show that the average torque of the machine has been significantly increased compared to the reference model. The detailed comparison results are provided in this paper

SEDG: Scalable and Efficient Data Gathering Routing Protocol for Underwater WSNs

AbstractIn recent years, the use of Autonomous Underwater Vehicle (AUV) along a constrained path can improve the data delivery ratio and maximize the energy efficiency in Underwater Wireless Sensor Networks (UWSNs). However, constant speed of AUV leads to limited communication to collect data packet from nodes deployed randomly in large scalable network. Moreover, the excessive number of associated nodes with Gateway Node (GN) causes to quick depletion of its energy, thus lead to hot spot problem. This poses prominent challenges in jointly improving the throughput with minimum energy consumption. To address these issues, we presented a novel scalable data gathering scheme called Scalable and Efficient Data Gathering SEDG routing protocol, that increases the packet delivery ratio as well as conserves limited energy by optimal assignment of member nodes with GN. Moreover, the variable sojourn interval of AUV decreases the packet drop ratio and hence, maximize the throughput of network

Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)

Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To the best of our knowledge, no comprehensive analysis has been undertaken on the cytotoxicity and cellular pathways involved in ovarian cancer cells, particularly SKOV3 cells. Here, we investigated the effect of palladium NPs (PdNPs) and the molecular mechanisms and cellular pathways involved in ovarian cancer. We assayed cell viability, proliferation, cytotoxicity, oxidative stress, DNA damage, and apoptosis and performed an RNA-Seq analysis. The results showed that PdNPs elicited concentration-dependent decreases in cell viability and proliferation and induced increasing cytotoxicity at increasing concentrations, as determined by leakage of lactate dehydrogenase, increased levels of reactive oxygen species and malondialdehyde, and decreased levels of antioxidants like glutathione and superoxide dismutase. Furthermore, our study revealed that PdNPs induce mitochondrial dysfunction by altering mitochondrial membrane potential, reducing adenosine triphosphate levels, inducing DNA damage, and activating caspase 3, all of which significantly induced apoptosis in SKOV3 cells following PdNPs treatment. Gene ontology (GO) term analysis of PdNPs-exposed SKOV3 cells showed various dysregulated pathways, particularly nucleosome assembly, telomere organization, and rDNA chromatin silencing. When genes downregulated by PdNPs were applied to GO term enrichment analysis, nucleosome assembly was the top-ranked biological pathway. We also provide evidence for an association between PdNPs exposure and multiple layers of epigenetic transcriptional control and establish a molecular basis for NP-mediated apoptosis. These findings provide a foundation, potential targets, and novel insights into the mechanism underlying toxicity and pathways in SKOV3 cells, and open new avenues to identify novel targets for ovarian cancer treatment